Use and efficacy of abciximab in an unselected population with acute myocardial infarction treated with primary angioplasty: Data from AMI-Florence registry
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference16 articles.
1. Primary angioplasty versus intravenous thrombolityc therapy for acute myocardial infarction: a quantitative review of 23 randomised trials;Keeley;Lancet,2003
2. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators;Brener;Circulation,1998
3. Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction;Neumann;J Am Coll Cardiol,2000
4. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction;Montalescot;N Engl J Med,2001
5. Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction;Stone;Circulation,2003
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3